C4 Therapeutics Inc. (CCCC)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
3. 87
+0.16
+4.3127%
After Hours
$
+0.06 +1.5504% 3. 93
410.2M Market Cap
- P/E Ratio
- Div Yield
2.36M Volume
-1.85 Eps
$ 3.71
Previous Close 
Want to track CCCC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
C4 Therapeutics Inc. (CCCC) Statistics
Valuation metrics
Market Cap 410.2M
Enterprise value 403.93M
Trailing P/E (ttm) -3.85
Forward P/E -
PEG ratio -0.08
Price/Sales (ttm) 12.15
Price/Book (mrq) 2.03
Enterprise Value/Revenue 11.53
Enterprise Value/EBITDA -4.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.82M
Average volume (90 days) 3.73M
Price summary
52-Week low 1.69
52-Week high 5.17
Beta -
50-Day moving average 3.64
200-Day moving average 2.98
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.89%
Operating margin -3.19%
Operational effectiveness
Return on assets -0.28%
Return on equity -0.45%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.27
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.94
Total debt (mrq) -
Total Debt/Equity (mrq) 0.23
Current ratio (mrq) 5.45%
Book value per share (mrq) 1.89
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
